Hopp Children’s Cancer Center Heidelberg (KiTZ) is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), and Heidelberg University (Uni HD).
The "Web of Science Group" of the U.S. company Clarivate publishes an annual ranking of the world's most cited scientists in 21 different subject areas, covering all natural sciences, medicine, economics, and social sciences.
In 2021, 6602 researchers from over 60 countries worldwide are among the top one percent of the most cited experts in their respective fields. This year, the 345 researchers from German institutions include eight scientists from the German Cancer Research Center (DKFZ).
Among the best of 2021 are:
- Ralf Bartenschlager (DKFZ and Heidelberg University Hospital) has paved the way for developing effective drugs against the dangerous pathogen with his groundbreaking research findings on the hepatitis C virus (Microbiology category).
- Epidemiologist Hermann Brenner (DKFZ and NCT Heidelberg) is considered a leading expert in the evaluation of cancer prevention measures (Cat. Cross Fields).
- Eran Elinav is an expert on the health effects of the gut microbiome. He works at the Weizmann Institute in Israel and heads a research unit at DKFZ that focuses on the influence of the microbiome on carcinogenesis (Cat. Molecular Biology and Genetics).
- Andreas von Deimling (DKFZ and Heidelberg University Hospital) is internationally known for developing diagnostic antibodies that can detect cancer-specific mutations and are used worldwide to better assess brain tumors (Cat. Neuroscience).
- Mathias Heikenwälder researches how chronic inflammation causes cancer to develop and how these processes can be stopped. He publishes his results in journals of various disciplines (cat. Cross Fields).
- Stefan Pfister, DKFZ and Hopp Children's Cancer Center „KiTZ", is one of the world's most renowned experts on the molecular genetics of childhood brain tumors. As such, he also has a considerable influence on the treatment of young patients and therefore, also publishes in journals for clinical medicine (cat. Cross Fields)
- Oliver Stegle (DKFZ and EMBL) develops methods for the analysis of high-throughput data. One focus here is on methods to study hereditary variations in single cells (cat. Cross Fields).
- Neurologist Wolfgang Wick (DKFZ and Heidelberg University Hospital) is investigating the molecular mechanisms of potential targeted therapies against glioblastoma (cat. Cross Fields).
For the current list, Clarivate considered the authors of all scientific publications that appeared between 2010 and 2020 and that were among the one percent of most cited scientific papers at the end of 2020 ("highly cited papers").
Depending on the size of the field, it requires a different number of citations to be counted among the top one percent. By far, the majority of "most cited researchers" come from U.S. institutions (2622), followed by China (935), the United Kingdom (492), Australia (332), and Germany (331).
